Publications by authors named "Malcolm Carter"

Claim this Profile
I
Identification of [4-[4-(methylsulfonyl)phenyl]-6-(trifluoromethyl)-2-pyrimidinyl] amines and ethers as potent and selective cyclooxygenase-2 inhibitors.
Martin E Swarbrick, Paul J Beswick, Robert J Gleave, Richard H Green, Sharon Bingham, Malcolm C Carter

Bioorg Med Chem Lett· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RSV604, a novel inhibitor of respiratory syncytial virus replication.
Joanna Chapman, Elizabeth Abbott, Dagmar G Alber, Robert C Baxter, Sian K Bithell, Malcolm C Carter

Antimicrob Agents Chemother· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bonding properties of newly erupted and mature premolars.
Eser Tüfekçi, Diana M Almy, J Malcolm Carter, Peter C Moon, Steven J Lindauer

Am J Orthod Dentofacial Orthop· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1,4-benzodiazepines as inhibitors of respiratory syncytial virus. The identification of a clinical candidate.
Elisa A Henderson, Dagmar G Alber, Robert C Baxter, Sian K Bithell, Joanna Budworth, Malcolm C Carter

J Med Chem· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series.
Kimberly G Petrov, Yue-Mei Zhang, Malcolm Carter, G Stuart Cockerill, Scott Dickerson

Bioorg Med Chem Lett· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1,4-Benzodiazepines as inhibitors of respiratory syncytial virus.
Malcolm C Carter, Dagmar G Alber, Robert C Baxter, Sian K Bithell, Jo Budworth

J Med Chem· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis